Course contents
Patient Selection & Skin of Color (Fitzpatrick IV–VI)5 min readUpdated 8 June 2026

Priming Protocols for Darker Skin

Why and how to prime Fitzpatrick IV–VI skin before a peel — retinoid, AHA, tyrosinase inhibitors and photoprotection — the agents, the duration, and how priming lowers post-inflammatory hyperpigmentation risk.

Priming is the weeks-long pre-conditioning of skin before a peel, and in Fitzpatrick IV–VI it is close to mandatory rather than optional. It does two distinct jobs: it standardises penetration so a given protocol lands at the same, intended depth every time, and it quiets the melanocytes so the canvas is less pigment-reactive before any inflammation occurs. Both directly lower post-inflammatory hyperpigmentation (PIH) risk — the central concern when peeling darker skin.

Why prime darker skin specifically

Two problems are worse in melanocompetent skin, and priming addresses both.

First, unpredictable penetration. A thick, variably hyperkeratotic stratum corneum lets an acid penetrate patchily — too little in some areas, too deep in others — producing uneven results and localised over-injury that seeds PIH. A retinoid normalises epidermal turnover and thins the stratum corneum, so the same peel penetrates evenly and predictably.

Second, melanocyte lability. Darker skin converts inflammation into pigment readily. Starting a tyrosinase inhibitor weeks before the peel lowers baseline melanogenic drive, so when the controlled injury does occur, the melanocytes respond less. Priming is, in effect, pre-loading the denominator of the PIH risk equation.

The priming toolkit

Agent classRole in primingPractical notes
RetinoidNormalises turnover, thins stratum corneum, standardises penetrationThe backbone of priming; start low, build tolerance; pause a few days pre-peel
Tyrosinase inhibitorQuiets melanocytes, lowers baseline pigment driveKojic acid, arbutin, liquorice and similar agents; the key PIH-lowering term
Low-strength AHAGentle ongoing exfoliation, smooths the canvasOptional; useful where a retinoid alone is poorly tolerated
Broad-spectrum sunscreenRemoves the dominant UV trigger from day oneNon-negotiable throughout priming, not just after the peel

The retinoid plus tyrosinase inhibitor pairing is the core; the AHA is a useful adjunct, and photoprotection runs underneath all of it for the entire priming window.

How long to prime

Duration is a clinical judgement, not a fixed rule, but useful anchors:

  • 2–4 weeks is a typical priming window for a straightforward Fitzpatrick IV–V patient with a stable barrier.
  • Longer (4–6+ weeks) is sensible in highly labile skin, active or melasma-prone pigment, or where tolerance to the retinoid has to be built gradually.
  • Pause the retinoid for a few days immediately before the peel to avoid stacking irritation on the day of treatment.

The endpoint you are looking for is skin that is tolerating its actives comfortably, with a calm, intact barrier — not skin that is pink, peeling or irritated going into the peel.

The priming workflow

Priming a Fitzpatrick IV–VI patient, step by step
  1. Confirm candidacy and baseline
    Document Fitzpatrick type, PIH/melasma history, barrier status and baseline pigment before starting any active.
  2. Start photoprotection from day one
    Begin strict daily broad-spectrum sunscreen immediately — it is part of priming, not just aftercare.
  3. Introduce the retinoid
    Start at a low strength/frequency and build up, to normalise turnover and standardise penetration without provoking irritation.
  4. Add a tyrosinase inhibitor
    Layer in a depigmenting agent (e.g. kojic acid, arbutin, liquorice) to lower baseline melanogenic drive over the weeks before the peel.
  5. Monitor tolerance
    Review for irritation, over-exfoliation or barrier compromise; dial back if the skin is reactive — intolerance now predicts a difficult peel.
  6. Pause actives pre-peel
    Stop the retinoid a few days before the peel so you are not stacking irritation on treatment day.
  7. Proceed only on a calm barrier
    Peel when the skin is comfortable, intact and tolerating its regimen — not while it is pink or peeling.

Priming as a screening tool

Beyond preparation, priming is a low-cost screening test. A patient who cannot tolerate a gentle retinoid over a few weeks is telling you their skin is reactive and that a full peel will be harder to control — far better to learn this during priming than during the peel itself. Use the priming window to read the skin's behaviour and adjust the planned protocol accordingly.

Key takeaway

Prime darker skin to make penetration predictable and melanocytes calm before any injury. A retinoid and a tyrosinase inhibitor over 2–4 weeks (longer when labile), under strict photoprotection, lowers PIH risk, improves the evenness of the result, and screens out the patients who will not tolerate the peel. In Fitzpatrick IV–VI, skipping the prime is skipping the safety margin.

Frequently asked questions

Why is priming important before peeling darker skin?

Priming standardises how deeply the peel penetrates so the result is even, and it lowers baseline melanocyte activity so the skin is less likely to develop post-inflammatory hyperpigmentation. It also reveals intolerance to actives before a full peel is performed. In Fitzpatrick IV–VI it is close to mandatory.

How long should priming last?

Typically 2–4 weeks for a straightforward Fitzpatrick IV–V patient, and longer (4–6 weeks or more) for highly reactive, melasma-prone or treatment-naïve skin where the retinoid must be built up gradually. Pause the retinoid for a few days immediately before the peel.

Which agents are used to prime Fitzpatrick IV–VI skin?

A retinoid to normalise turnover and standardise penetration, a tyrosinase inhibitor (such as kojic acid, arbutin or liquorice) to quiet melanocytes, an optional low-strength AHA, and strict broad-spectrum photoprotection throughout the priming window.

References

  1. DermNet — Chemical peel (preparation and priming).
  2. DermNet — Postinflammatory hyperpigmentation.
  3. Soleymani T, Lanoue J, Rahman Z. A Practical Approach to Chemical Peels (priming and pre-treatment). J Clin Aesthet Dermatol. 2018;11(8):21–28.